|
General Information
|
|
|
Product
|
EHD3 Peptide
|
|
Description
|
Antigenic Blocking Peptide EH domain-containing protein 3 Antibody
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 475-535 on human EH-domain containing protein 3.
|
|
Accession #
|
NCBI: NP_055416.2
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q9NZN3
|
|
Overview
|
Plays a role in endocytic transport
|
|
Molecular Function
|
ATP binding;GTPase activity;nucleic acid binding;calcium ion binding;GTP binding
|
|
Subcellular Location
|
Cell membrane, Cytoplasm, Endosome, Membrane
|
|
Expression
|
Highly expressed in heart and brain and moderately expressed in kidney, liver, and placenta.
|
|
Structure
|
Homooligomer, and heterooligomer with EHD1, EHD2 and EHD4
|
|
Alternative Nomenclature
|
EH domain containing 3 antibody
EHD2 antibody
EHD3 antibody
PAST3 antibody
|
| |
|
EHD3 Antibody
EHD3 Antibody FITC
EHD3 Antibody BIOTIN
EHD3 Positive Control
